LIVER TRANSPLANTATION, Organ Failure, Multiple
Conditions
Brief summary
ELECTRONIC ARCHIVE OF INTERNAL MEDICINE FOR THE TREATMENT OF SERIOUS ORGAN FAILURES AND LIVER TRANSPLANTATION
Detailed description
This is an observational, spontaneous, monocentric study with structured data collection from the medical records of patients diagnosed with acute or chronic liver failure. The study will involve both retrospective and prospective data collection: Retrospective data collection: Patients diagnosed between 01/01/2013 and the start date of the study. Prospective data collection: Patients diagnosed after the start of the study until the end of the recruitment period (10 years).
Interventions
None listed
Sponsors
IRCCS Azienda Ospedaliero-Universitaria di Bologna
Study design
Observational model
COHORT
Time perspective
OTHER
Eligibility
Sex/Gender
ALL
Age
18 Years to No maximum
Healthy volunteers
No
Inclusion criteria
* Diagnosis of acute or chronic liver disease or LT * Age ≥ 18 years * Obtaining informed consent
Exclusion criteria
* no one
Design outcomes
Primary
| Measure | Time frame | Description |
|---|---|---|
| Incidence of Complications in Chronic Liver Disease | 10 years | This measure aims to assess the incidence of complications associated with chronic liver disease in patients followed at the U.O. of Internal Medicine and the Liver Transplant Program of the IRCCS AOUBO. |
| Number of Liver Transplantation Candidates Evaluated | 10 years | This measure tracks the number of patients evaluated for liver transplantation at the U.O. of Internal Medicine and the Liver Transplant Program of the IRCCS AOUBO |
| Number of Liver Transplants Performed Annually | 10 years | This measure tracks the number of liver transplants performed annually at the U.O. of Internal Medicine and the Liver Transplant Program of the IRCCS AOUBO. |
| Epidemiological classification of Acute or Chronic Liver Disease and Liver Transplant Candidates at the U.O. of Internal Medicine | 10 years | This indicator will evaluate the main diagnostic states and substates of patients with acute or chronic liver disease and/or liver transplantation, followed at the U.O. of Internal Medicine for serious organ failure and the Liver Transplant Program of the IRCCS AOUBO. |
| Hospitalization Rates | 10 years | This section analyzes the hospitalization rates of patients with acute and chronic liver diseases, highlighting the frequency of hospital stays. |
Secondary
| Measure | Time frame | Description |
|---|---|---|
| Survival Rate Quantification | 10 years | This measure aims to quantify survival rates for the entire population of patients with acute or chronic liver disease and/or liver transplantation, followed at the U.O. of Internal Medicine for serious organ failure and the Liver Transplant Program of the IRCCS AOUBO. Survival outcomes will be assessed starting from diagnosis, with rates measured at 1, 3, 5, and 10 years post-diagnosis |
| Description of Prescribed Treatments and Variations for Acute or Chronic Liver Disease and Liver Transplant Candidates at the U.O. of Internal Medicine | 10 years | This measure aims to describe the prescribed treatments and any variations made for the entire population of patients with acute or chronic liver disease and/or liver transplantation, followed at the U.O. of Internal Medicine for serious organ failure and the Liver Transplant Program of the IRCCS AOUBO. Treatment data will be collected, including the specific therapies prescribed at diagnosis and during follow-up, as well as any modifications to the treatment plan based on patient response or clinical changes |
Countries
Italy
Contacts
Primary ContactGiovanni Vitale, MD
Outcome results
None listed